Learn how the Medicare GLP 1 Bridge Program works, who may qualify, and what steps are involved in getting started. This guide explains Medicare Part D requirements, eligible medications, provider involvement, prescription processing, prior authorization, and important considerations for people exploring GLP 1 treatment for weight management under the temporary program.
The Medicare GLP 1 Bridge Program is a temporary program designed to provide eligible Medicare beneficiaries with access to certain GLP 1 medications for weight management. The program began July 1 2026 and is scheduled to continue through December 31 2027. Eligibility depends on Medicare coverage, medical criteria, the intended use of treatment, and other requirements. There is not a separate consumer enrollment application in the usual sense. Instead, eligible individuals generally begin by discussing treatment with a healthcare provider, who can prescribe an eligible medication and complete prior authorization when required. Understanding the process can help individuals prepare for conversations with their healthcare team and pharmacy.
The Medicare GLP 1 Bridge Program is a CMS demonstration that operates separately from standard Medicare Part D drug coverage. It is intended for eligible Medicare beneficiaries who meet specific requirements for GLP 1 medications used for weight management. The program started July 1 2026 and is scheduled to run through December 31 2027.
Key points to understand include:
Before getting started, individuals generally need to meet Medicare and clinical requirements. CMS states that eligible participants must be at least 18 years old and have qualifying Medicare Part D coverage. Other requirements relate to BMI and certain health conditions.
Factors considered can include:
People with certain conditions, including type 2 diabetes, moderate to severe sleep apnea, or MASH, may not qualify for the Bridge program because their medication coverage may instead be handled through their Part D plan.
There is not necessarily a traditional online enrollment form for beneficiaries. Medicare explains that eligible individuals should talk with their healthcare provider to get started. The provider can determine whether a covered medication may be appropriate and send the prescription to a pharmacy.
The general process may involve:
The pharmacy may request the Medicare Number or the last four digits of the Social Security number to process the prescription.
The Medicare GLP 1 Bridge currently covers specific medications when prescribed for qualifying weight management purposes. CMS identifies Foundayo, Wegovy, and Zepbound KwikPen among the covered products. Certain Zepbound formulations, including single dose vials and pens, are not included.
It is also important to understand that not every GLP 1 medication is included in the Bridge program. Some medications may have coverage through Medicare Part D when used for other medically accepted indications.
Once a prescription is submitted, the program's centralized system can check eligibility and handle the prior authorization process when required. If authorization is approved, the pharmacy can process the prescription under the Bridge program. Medicare states that prior authorization can remain valid through December 31 2027 unless the person changes GLP 1 medications.
Individuals can consider asking their healthcare provider: